BrainZell

BrainZell specializes in generating high-throughput brain organoids derived from induced pluripotent stem cells (iPSCs). Their innovative platform closely mimics human neural biology, utilizing an automated process with rigorous quality checks at every stage. They aim to accelerate the development of life-changing therapies by providing a high-throughput drug discovery platform for neural activity testing, toxicity assessment, and custom assays.